October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting episode artwork

EPISODE · Oct 10, 2023

October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting

from AAD's Dialogues in Dermatology

Pim Aarts, MD interviewed by Olayemi Sokumbi, MD, FAAD

Episode metadata supplied by the publisher feed · Published Oct 10, 2023

Embed this episode

NOW PLAYING

October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

When was this AAD's Dialogues in Dermatology episode published?

This episode was published on October 10, 2023.

Can I download this AAD's Dialogues in Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!